Long‐term continuous terlipressin infusion in cirrhotic patients with hepatorenal syndrome or refractory ascites awaiting liver transplantation is associated with an increase in plasma sodium-Reference-Cited by-同舟云学术

Long‐term continuous terlipressin infusion in cirrhotic patients with hepatorenal syndrome or refractory ascites awaiting liver transplantation is associated with an increase in plasma sodium

Published:2019-11 Issue:9 Volume:7 Page:1271-1273
ISSN:2050-6406
Container-title:United European Gastroenterology Journal
language:en
Short-container-title:United European Gastroenterol. j.

Author:

McClure T¹²,Chapman B¹²,Hey P¹²,Testro A¹²,Gow P¹²

Affiliation:

1. Liver Transplant UnitAustin HospitalMelbourneAustralia

2. Department of Medicine, Dentistry and Health SciencesThe University of MelbourneMelbourneAustralia

Publisher

Wiley

Subject

Gastroenterology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2050640619878996

Reference9 articles.

1. Terlipressin for variceal bleeding induces large plasma sodium fluctuations in patients without cirrhosis

2. Effects of terlipressin on the aquaretic system: evidence of antidiuretic effects

3. Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome;Allegretti AS;Cochrane Database Syst Rev,2017

4. Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study

5. Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential augmentation of terlipressin antidiuretic effects by gabapentinoids;Journal of Hepatology;2024-08

2. From past to present to future: Terlipressin and hepatorenal syndrome-acute kidney injury;Hepatology;2024-02-14

3. Impact of octreotide on sodium level in cirrhotic inpatients with hyponatremia: a retrospective study;European Journal of Gastroenterology & Hepatology;2023-09-08

4. Terlipressin in the management of liver disease;Expert Opinion on Pharmacotherapy;2023-08-07

5. HEP-Net opinion on the management of ascites and its complications in the setting of decompensated cirrhosis in the resource constrained environment of Pakistan;Pakistan Journal of Medical Sciences;2020-06-26